[Azapropazone plasma levels in rheumatologic therapy with D-penicillamine combined with immunosuppressive agents].
D000328:Adult; D001032:Apazone / Q000097:blood* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000097:blood* / Q000188:drug therapy; D001379:Azathioprine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D008875:Middle Aged; D010396:Penicillamine / Q000494:pharmacology* / Q000627:therapeutic use; D011033:Podophyllin / Q000627:therapeutic use; D014227:Triazines / Q000097:blood*
D007166:Immunosuppressive Agents; D014227:Triazines; D011033:Podophyllin; D010396:Penicillamine; D001032:Apazone; D001379:Azathioprine
Azapropazon-Plasmaspiegel unter rheumatologischer Kombinationstherapie mit D-Penicillamin und Immunsuppressiva.